Nuclear pore glycoprotein-210 (gp210) is an essential trafficking regulator in the eukaryotic nuclear pore complex. Gp-210 anchors the pore complex to the nuclear membrane. and protein tagging reveals its primarily located on the luminal side of double layer membrane at the pore. A single polypeptide motif of gp210 is responsible for sorting to nuclear membrane, and indicate the carboxyl tail of the protein is oriented toward the cytoplasmic side of the membrane.The deduced protein contains 1,886 amino acids. Northern blot analysis detected a 7.5-kb transcript. In situ hybridization detected preferential expression in epithelial cells. In kidney, expression was seen in both the epithelium derived from the ureteric tree and the mesenchyme-derived epithelium.

Rat Anti-glucoprotein 210 antibody (GP210-Ab) ELISA Kit employs the competitive enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with an antibody specific to GP210-Ab. Standards or samples are then added to the appropriate microtiter plate wells with a Horseradish Peroxidase (HRP)-conjugated GP210-Ab and incubated. The competitive inhibition reaction is launched between with HRP labeled GP210-Ab and unlabeled GP210-Ab with the antibody. A substrate solution is added to the wells and the color develops in opposite to the amount of GP210-Ab in the sample. The color development is stopped and the intensity of the color is measured.

Rat Anti-glucoprotein 210 antibody (GP210-Ab) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/rat-anti-glucoprotein-210-antibody-gp210-ab-elisa-kit-kte100930/

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.